Bone Marrow TransplantationTissue DonorsHistocompatibility TestingHistocompatibilityGraft vs Host DiseaseTransplantation, HomologousGraft SurvivalBone MarrowAnemia, AplasticUnrelated DonorsLeukemiaBone Marrow CellsTransplantation ChimeraSurvival AnalysisTransplantation ConditioningRecurrenceWhole-Body IrradiationHematopoietic Stem Cell TransplantationTreatment OutcomeTransplantation, AutologousGraft RejectionBone and BonesHLA AntigensTransplantation, IsogeneicImmunosuppressive AgentsHematologic NeoplasmsBusulfanHematopoietic Stem CellsLiver TransplantationRadiation ChimeraKidney TransplantationGraft Enhancement, ImmunologicTransplantation ToleranceLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionTransplantation ImmunologyImmunosuppressionLeukocyte TransfusionMice, Inbred C57BLActuarial AnalysisBone Marrow PurgingSkin TransplantationChimerismCyclophosphamideTime FactorsAcute DiseaseCord Blood Stem Cell TransplantationLiving DonorsT-LymphocytesHeart TransplantationLeukemia, Myeloid, AcuteBone Marrow DiseasesDisease-Free SurvivalRemission InductionHematopoiesisCombined Modality TherapyBlood DonorsStem Cell TransplantationRetrospective StudiesMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseHematologic DiseasesBone Marrow ExaminationLeukemia, MyeloidLymphocyte Culture Test, MixedLymphocyte TransfusionAntilymphocyte SerumSevere Combined ImmunodeficiencyChimeraSurvival RateBone RemodelingPeripheral Blood Stem Cell TransplantationCyclosporineGraft vs Host ReactionBone Marrow NeoplasmsLymphoma, Non-HodgkinMice, Inbred BALB CFollow-Up StudiesGraft vs Tumor EffectGraft vs Leukemia EffectNuclear FamilyColony-Forming Units AssayCytomegalovirus InfectionsLung TransplantationMelphalanAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBone DensityLeukocyte CountInfectionMice, Inbred C3HSiblingsImmune ToleranceGranulocyte Colony-Stimulating FactorCytarabineOrgan TransplantationVidarabineFlow CytometryCarmustine